©The Author(s) 2025.
World J Orthop. Oct 18, 2025; 16(10): 110562
Published online Oct 18, 2025. doi: 10.5312/wjo.v16.i10.110562
Published online Oct 18, 2025. doi: 10.5312/wjo.v16.i10.110562
Table 2 Comparative costs of alginate produced by different companies from algae and bacteria
| Volume, g | Cost, $ | Manufacturing companies | |
| Bacterial | 5 | 950-1150 | Biosynth (Switzerland), USBiological Life Sciences (United States) |
| Algal | 25 | ≈ 18 | Flinn Scientific (Canada), Carolina Biological Supply (United States) |
| 500 | 70-270 | Merck (Germany), Snow Sea (Russia), Fisher Scientific International, Inc. (United States) | |
| 1000 | 125-550 | Merck (Germany), MSK Ingredients (United Kingdom), Fisher Scientific International, Inc. (United States) |
- Citation: Dudun AA, Bonartseva GA, Bonartsev AP. Alginate-based biomaterials in orthopedics: What are the prospects for bacterial alginate? World J Orthop 2025; 16(10): 110562
- URL: https://www.wjgnet.com/2218-5836/full/v16/i10/110562.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i10.110562